Home / Stocks / Icicipramc - Bharatiwin
ICICIB22

Icicipramc - Bharatiwin Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹118.73

Change

+1.91 (1.63%)

Open

₹115.65

Prev. Close

₹116.82

Day High

₹118.89

Day Low

₹115.65

Volume Analysis

Traded

842,219

Delivered

597,153

Delivery %

70.9%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹123.11 ₹121.0 ₹119.87 ₹117.76 ₹116.63 ₹114.52 ₹113.39
Fibonacci ₹121.0 ₹119.76 ₹119.0 ₹117.76 ₹116.52 ₹115.76 ₹114.52
Camarilla ₹119.62 ₹119.32 ₹119.03 ₹117.76 ₹118.43 ₹118.14 ₹117.84

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+1.08%

1 Week

+1.91%

1 Month

+11.37%

3 Months

+2.99%

6 Months

-1.39%

1 Year

+1.14%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Company Overview

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Icicipramc - Bharatiwin holds up reasonably well on TopFund's composite fundamentals check, at 72/100. The strongest factor is Liquidity (74/100), while Risk & Volatility (70/100) is the weakest area to weigh before deciding.

TopFund Score — Fundamentals Quality

72/100 — Good

Data confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Risk & Volatility

70

Liquidity

74

Not investment advice — an automated read of public fundamentals data, for research context only.

Which Mutual Funds Hold Icicipramc - Bharatiwin?

Frequently Asked Questions about Icicipramc - Bharatiwin

Community Sentiment

What are other investors saying about Icicipramc - Bharatiwin?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.